Pancreatic Cancer Research

ResearcherUNSW SydneyNo recent work listed

Srinivasa P. Pothula

Matched on ORCID iD 0000-0003-3204-8693; OpenAlex author ID A5087142035. Sources: OpenAlex.

Their work

Papers
12 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: 2 papers · 2017: 2 papers · 2018: none · 2019: none · 2020: 5 papers · 2021: 1 paper

Papers 12

  1. HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic Cancer. Co-author DOI 10.3390/cancers13112763↗
  2. Pancreatic stellate cells: Aiding and abetting pancreatic cancer progression. Co-author DOI 10.1016/j.pan.2020.01.003↗
  3. Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis. Co-author DOI 10.1038/s41416-020-0782-1↗
  4. Reply letter to comments on: Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and el… First author DOI 10.1038/s41416-020-1004-6↗
  5. Targeting HGF/c-MET Axis in Pancreatic Cancer. Co-author DOI 10.3390/ijms21239170↗
  6. An Orthotopic Resectional Mouse Model of Pancreatic Cancer. Co-author DOI 10.3791/61726↗
  7. Circulating pancreatic stellate (stromal) cells in pancreatic cancer-a fertile area for novel research. Co-author DOI 10.1093/carcin/bgx030↗
  8. Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer. Co-author DOI 10.18632/oncotarget.20822↗
  9. Key role of pancreatic stellate cells in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2015.10.035↗
  10. Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer. Co-author DOI 10.1038/bjc.2015.478↗
  11. Pancreatic cancer: The microenvironment needs attention too! Co-author DOI 10.1016/j.pan.2015.02.013↗
  12. The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: antiangiogenic implications in pancreatic can… First author DOI 10.1093/carcin/bgu122↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Minoti Vivek Apte · 12 shared papers, 2014–2021 · strength 1.16
  2. Jeremy S. Wilson · 12 shared papers, 2014–2021 · strength 1.16
  3. David Goldstein · 11 shared papers, 2014–2021 · strength 1.00
  4. Zhihong Xu · 11 shared papers, 2014–2021 · strength 1.00
  5. Tony Pang · 4 shared papers, 2017–2021 · strength 0.42
  6. Takashi Murakami · 1 shared paper, 2020 · strength 0.11
  7. Chamini Jayamali Perera · 1 shared paper, 2020 · strength 0.11
  8. Neil Donald Merrett · 1 shared paper, 2017 · strength 0.08
  9. Andrew Victor Biankin · 1 shared paper, 2016 · strength 0.07
  10. Mishaal B. Patel · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.